Introduction: A pterygium is a triangular wedge of fibro-vascular conjunctival tissue that appears on the epibulbar conjunctiva, which can be removed by various methods. Recurrence of Pterygium after exicision is a very common problem encountered by ophthalmologist. Several methods have been suggested to avoid these recurrences. We studied the recurrence rate of pterygium after application of intraoperative mitomycin C (0.04%). Method: This is a prospective study of fifty eyes in fifty patients who underwent pterygium excision by the same surgeon using intraoperative topical mitomycin C(25 patients) and without using mitomycin c(25 patients) during September 20014—September 2015 in the ophthalmology department at Jhalawar medical college, J...
<b>AIM:</b>Toevaluate the recurrence andcomplicationsafter bare sclera resection (BSR) combined with...
Copyright © 2013 Achyut N. Pandey et al. This is an open access article distributed under the Creati...
Purpose To observe the efficiency of intraoperative low-dose Mitomycin-C combined with conjunctival ...
Background: The major problem in the treatment of pterygium is to prevent recurrences after surgical...
Background: Pterygium recurrence rate after simple surgical excision is high. Many adjunctive treatm...
Purpose: To compare various techniques of pterygium surgery including bare sclera, intraoperative mi...
Background and objectives: Recurrent pterygium is an important ocular problem in our country. There...
This study was designed to evaluate the possible complications following the use of intraoperative m...
Aims: This study was designed to evaluate Pterygium surgery and intra-operative mitomycin C applicat...
Introduction & Objective: Pterygium is a wing-shaped fold of conjunctiva and fibrovascular tissue ...
Pterygium is a triangular sheet of fibrovascular tissue that invades the clear cornea from the bulba...
Objective: To assess the safety and efficacy of 0.04% MMC in reducing the rate of pterygium recurren...
AIM: To compare the clinical efficacy of treatment on recurrent pterygium using different concentrat...
Objectives: We aimed at the recurrence rate determination subsequent to Conjunctival Autograft again...
Purpose: To determine the minimum effective dosage, most effective route of administration and long-...
<b>AIM:</b>Toevaluate the recurrence andcomplicationsafter bare sclera resection (BSR) combined with...
Copyright © 2013 Achyut N. Pandey et al. This is an open access article distributed under the Creati...
Purpose To observe the efficiency of intraoperative low-dose Mitomycin-C combined with conjunctival ...
Background: The major problem in the treatment of pterygium is to prevent recurrences after surgical...
Background: Pterygium recurrence rate after simple surgical excision is high. Many adjunctive treatm...
Purpose: To compare various techniques of pterygium surgery including bare sclera, intraoperative mi...
Background and objectives: Recurrent pterygium is an important ocular problem in our country. There...
This study was designed to evaluate the possible complications following the use of intraoperative m...
Aims: This study was designed to evaluate Pterygium surgery and intra-operative mitomycin C applicat...
Introduction & Objective: Pterygium is a wing-shaped fold of conjunctiva and fibrovascular tissue ...
Pterygium is a triangular sheet of fibrovascular tissue that invades the clear cornea from the bulba...
Objective: To assess the safety and efficacy of 0.04% MMC in reducing the rate of pterygium recurren...
AIM: To compare the clinical efficacy of treatment on recurrent pterygium using different concentrat...
Objectives: We aimed at the recurrence rate determination subsequent to Conjunctival Autograft again...
Purpose: To determine the minimum effective dosage, most effective route of administration and long-...
<b>AIM:</b>Toevaluate the recurrence andcomplicationsafter bare sclera resection (BSR) combined with...
Copyright © 2013 Achyut N. Pandey et al. This is an open access article distributed under the Creati...
Purpose To observe the efficiency of intraoperative low-dose Mitomycin-C combined with conjunctival ...